6C42.23

ICD-11 MMS 2026-01

Synthetic cannabinoid dependence, sustained full remission

Description

After a diagnosis of synthetic cannabinoid dependence, and often following a treatment episode or other intervention (including self-intervention), the person has been abstinent from synthetic cannabinoid use for 12 months or longer.

Index terms

  • Synthetic cannabinoid dependence, sustained full remission

Excludes

  • 6C42.0 – Episode of harmful use of synthetic cannabinoids
  • 6C42.1 – Harmful pattern of use of synthetic cannabinoids

Exclusions from above levels

  • 6C41 – Disorders due to use of cannabis
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C42.20 – Synthetic cannabinoid dependence, current use
  • 6C42.21 – Synthetic cannabinoid dependence, early full remission
  • 6C42.22 – Synthetic cannabinoid dependence, sustained partial remission
  • 6C42.2Y – Other specified synthetic cannabinoid dependence
  • 6C42.2Z – Synthetic cannabinoid dependence, unspecified

Foundation entity

Synthetic cannabinoid dependence, sustained full remission – http://id.who.int/icd/entity/819411618

Allowed postcoordination axes

Part of: 6C42.2: Synthetic cannabinoid dependence › 6C42: Disorders due to use of synthetic cannabinoids › 06: Mental, behavioural or neurodevelopmental disorders